Abstract: . . .  FOR PORTAL HYPERTENSION Chairmen: W. Jimenez and R. Moreau S.Fiorucci (Italy) Selective hepatic delivery of NO donors F. Nevens (Belgium) Effect of eNOS gene transfer on portal hypertension K. Moore (UK) Treatment of vascular dysfunction in liver disease : The future 18.30 POSTER SESSION WITH BEER and WINE All delegates will be invited to present some of their work in this poster session. Beer and wine will be provided together with some light snacks.  . . .
. . .  (Canada) Cardiac dysfunction in chronic liver disease Pt2 10.30 Coffee Break 11.00 CIRRHOTIC CARDIOMYOPATHY contd Chairman: R. Williams M Bernardi (Italy) Electromechanical abnormalities and autonomic dysfunction in cirrhosis. J Bosch (Spain) Is cirrhotic cardiomyopathy is an invention of medical science? F Wong (Canada) Cirrhotic cardiomyopathy is real, and here to stay Laurie Blendis CONCLUDING REMARKS 13.00 DEPARTURE  . . .
. . .  Loscalzo and C. Day S Lee (Canada ) Definition of cirrhotic cardiomyopathy. Experimental evidence and basic aspects S Mller (Denmark) Cardiac dysfunction in chronic liver disease Pt1 F. Wong (Canada) Cardiac dysfunction in chronic liver disease Pt2 10.30 Coffee Break 11.00 CIRRHOTIC CARDIOMYOPATHY contd Chairman: R. Williams M Bernardi (Italy) Electromechanical abnormalities and autonomic dysfunction in cirrhosis. J Bosch (Spain) . . .
. . .  and C. Day S Lee (Canada ) Definition of cirrhotic cardiomyopathy. Experimental evidence and basic aspects S Mller (Denmark) Cardiac dysfunction in chronic liver disease Pt1 F. Wong (Canada) Cardiac dysfunction in chronic liver disease Pt2 10.30 Coffee Break 11.00 CIRRHOTIC CARDIOMYOPATHY contd Chairman: R. Williams M Bernardi (Italy) Electromechanical abnormalities and autonomic dysfunction in cirrhosis. J Bosch (Spain)  . . .
--2244,4,280,2534,11222